
Biologics, or biopharmaceuticals, are medicines produced from living organisms using biotechnology techniques.

Biosimilars are new versions of existing biopharmaceuticals following loss of patent protection.

With decades of experience in biotechnology, it is no coincidence that Sandoz is leading the way in biosimilars.